This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fisch P, Handgretinger R, Schaefer HE . Pure red cell aplasia. Br J Haematol 2000; 111: 1010–1022.
Young NS, Abkowitz JL, Luzzatto L et al. New insights into the pathophysiology of acquired cytopenias.
Bierman PJ, Warkentin P, Hutchins MR, Klassen LW . Pure red cell aplasia following ABO mismatched marrow transplantation for chronic lymphocytic leukemia: response to antithymocyte globulin. Leuk Lymphoma 1993; 9: 169–171.
Veelken H, Wasch R, Behringer D et al. Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning Cyclosporin A for the treatment of pure red cell aplasia associated with myelodysplasia. Bone Marrow Transplant 2000; 26: 911–915.
Clark DA, Dessypris EN, Krantz SB . Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients. Blood 1984; 63: 277–286.
Tseng SB, Lin SF, Chang CS et al. Successful treatment of acquired pure red cell aplasia (PRCA) by allogeneic peripheral blood stem cell transplantation. Am J Hematol 2003; 74: 273–275.
Passweg JR, Rabusin M, Musso M et al. Haematopoietic stem cell transplantation for refractory autoimmune cytopenia. Br J Haematol 2004; 125: 749–755.
Martino R, Caballero MD, Canals C et al. Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study. Br J Haematol 2001; 115: 653–659.
Muller BU, Tichelli A, Passweg JR et al. Successful treatment of refractory acquired pure red cell aplasia (PRCA) by allogeneic bone marrow transplantation. Bone Marrow Transplant 1999; 23: 1205–1207.
de Vetten MP, van Gelder M, de Greef GE . Recovery of erythropoiesis following allogeneic bone marrow transplantation for chronic lymphocytic leukaemia-associated pure red cell aplasia. Bone Marrow Transplant 2001; 27: 771–773.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kochethu, G., Baden, H., Jaworska, E. et al. Reduced intensity conditioning bone marrow transplantation for pure red cell aplasia: successful outcome but difficult post transplant course. Bone Marrow Transplant 36, 81–82 (2005). https://doi.org/10.1038/sj.bmt.1704993
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704993
This article is cited by
-
Successful sirolimus treatment of patients with pure red cell aplasia complicated with renal insufficiency
Annals of Hematology (2020)
-
Successful treatment of refractory/relapsed acquired pure red cell aplasia with sirolimus
Annals of Hematology (2018)